source
- Cell and gene therapy funding climbs to $2.2 billion in Q3 despite safety setbacks in CAR-T trialsSail Biomedicine’s $925 million agreement with Johnson & Johnson helped lift venture capital money into the cell and gene therapy (CGT) space during the third quarter. CGT attracted $2.2 billion a…
- Four major drugmakers allegedly paid tens of millions to Russian middlemen for lifesaving drugs, limiting patient accessFour large pharmaceutical companies are accused of funneling tens of millions of dollars to Russian intermediaries to deliver essential medicines to government agencies, according to a report by th…